Pyka Łukasz, Hawranek Michał, Gąsior Mariusz
3 Department of Cardiology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Center for Heart Diseases, Zabrze, Poland.
Kardiochir Torakochirurgia Pol. 2017 Mar;14(1):37-42. doi: 10.5114/kitp.2017.66928. Epub 2017 Mar 31.
Heart failure is a growing problem worldwide, with coronary artery disease being the underlying cause of over two-thirds of cases. Revascularization in this group of patients may potentially inhibit the progressive damage to the myocardium and lead to improved outcomes, but data in this area are scarce. This article emphasizes the role of qualification for revascularization and selection of method (percutaneous coronary intervention vs. coronary artery bypass grafting) and subsequently focuses on the issue of completeness of revascularization in this group of patients.
心力衰竭在全球范围内是一个日益严重的问题,冠状动脉疾病是超过三分之二病例的潜在病因。对这组患者进行血运重建可能会潜在地抑制对心肌的渐进性损害并改善预后,但该领域的数据很少。本文强调血运重建的资格认定和方法选择(经皮冠状动脉介入治疗与冠状动脉旁路移植术)的作用,随后重点关注这组患者血运重建的完整性问题。